← All organizations

Hôpital Européen Georges-Pompidou

Academic/HospitalWebsite ↗

Also known as: AP-HP, Hôpital Européen Georges Pompidou, Paris | European Hospital Georges Pompidou | HOPITAL EUROPEEN GEORGES POMPIDOU | Hôpital Européen Georges-Pompidou | Hôpital Européen Georges Pompidou, Oncology department of Pr Stéphane OUDARD | Hôpital Européen Georges Pompidou, Paris, France | Medicine interne department, Europeen Georges Pompidou Hospital, Paris, France | Plateforme labellisée Inca – Hôpital Européen Georges Pompidou, Paris

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Dec 31, 2024

Timeline

No events for the selected filters.

Drugs by trial phase (28 distinct, 9 trials)

Phase 3 (20 own, 0 via acquisition)

Phase 2 (7 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

131i-lipiodol

Indications

Studied for

Recent trials (10)

NCT06475352OfficialPhase 2Dec 31, 2024
NCT05387954Study directorPhase 3Jun 1, 2022
NCT05387954OfficialPhase 3Jun 1, 2022
NCT04961528Study chairPhase 3Nov 1, 2021
NCT04733092Overall official - principal investigatorPhase 1Mar 3, 2021
NCT03784014CollaboratorPhase 3Mar 31, 2019
NCT03838263Overall official - principal investigatorPhase 2Mar 31, 2019
NCT03549715Overall official - principal investigatorPhase 1/Phase 2Sep 30, 2018
NCT03556956Overall official - principal investigatorPhase 2/Phase 3Jul 15, 2015
NCT03362684Overall official - principal investigatorPhase 3Nov 30, 2005

Details

Founded: Paris, FR
Last known activity: Dec 31, 2024